Similar articles

• Steroid receptors in breast tumors--current status.

  McGuire WL, Zava DT, Horwitz KB, Chamness GC. McGuire WL, et al. Curr Top Exp Endocrinol. 1978;3:93-129. Curr Top Exp Endocrinol. 1978. PMID: 350504 Review. No abstract available.
• Fluoresceinated estrone binding by human and mouse breast cancer cells.

  Fisher B, Gunduz N, Zheng S, Saffer EA. Fisher B, et al. Cancer Res. 1982 Feb;42(2):540-9. Cancer Res. 1982. PMID: 7055802 No abstract available.
• Current use of steroid hormone receptor assays in the treatment of breast cancer.

  Osborne CK, McGuire WL. Osborne CK, et al. Surg Clin North Am. 1978 Aug;58(4):777-88. doi: 10.1016/s0039-6109(16)41589-6. Surg Clin North Am. 1978. PMID: 684560 No abstract available.
• Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.

  Wittliff JL, Mehta RG, Boyd PA, Goral JE. Wittliff JL, et al. J Toxicol Environ Health Suppl. 1976;1:231-56. J Toxicol Environ Health Suppl. 1976. PMID: 186628 Review.
• Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.

  Leclercq G, Heuson JC. Leclercq G, et al. Eur J Cancer (1965). 1977 Nov;13(11):1205-15. doi: 10.1016/0014-2964(77)90026-3. Eur J Cancer (1965). 1977. PMID: 338304 Review. No abstract available.